Shareholders' Equity - Schedule of Warrants Activity (Details) - $ / shares |
12 Months Ended | |
---|---|---|
Oct. 31, 2020 |
Oct. 31, 2019 |
|
Stockholders' Equity Note [Abstract] | ||
Warrants Outstanding, Beginning balance | 525,000 | 829,400 |
Warrants Outstanding, Issued | 60,000 | 25,000 |
Warrants Outstanding, Expired | (329,400) | |
Warrants Outstanding, Exchanged | (25,000) | |
Warrants Outstanding, Ending balance | 560,000 | 525,000 |
Warrants Exercisable, Ending balance | 510,000 | |
Weighted Average Exercise Price Per Share Warrants Outstanding, Beginning balance | $ 4.98 | $ 7.04 |
Weighted Average Exercise Price Per Share, Issued | 2.06 | 4.04 |
Weighted Average Exercise Price Per Share, Expired | 10.09 | |
Weighted Average Exercise Price Per Share, Exchanged | 4.04 | |
Weighted Average Exercise Price Per Share Warrants Outstanding, Ending balance | 4.71 | $ 4.98 |
Weighted Average Exercise Price Per Share, Warrants Exercisable | $ 4.97 |
X | ||||||||||
- Definition Number of equity instruments other than options exercisable, including both vested and non-vested instruments. No definition available.
|
X | ||||||||||
- Definition Weighted Average Exercise Price Per Share, Warrants Exercisable. No definition available.
|
X | ||||||||||
- Definition Weighted Average Exercise Price Per Share Warrants Outstanding, Beginning balance. No definition available.
|
X | ||||||||||
- Definition Weighted Average Exercise Price Per Share, Exchanged. No definition available.
|
X | ||||||||||
- Definition Weighted Average Exercise Price Per Share, Exchanged. No definition available.
|
X | ||||||||||
- Definition Weighted Average Exercise Price Per Share, Issued. No definition available.
|
X | ||||||||||
- Definition Warrants Outstanding, Exchanged. No definition available.
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|